Impact-Site-Verification: 2721d812-1059-4270-b9fa-5c1654788cd1

Black Friday saleBuy 3 months, get 3 freeEnds Fri, Nov 27

Topical BPC-157 Creams and Gels: Do They Actually Work?

Get BPC-157 · from $99.50/mo → For sale on Rx.com · licensed U.S. pharmacy · prescription required

Marketers claim rubbing BPC-157 into sore knees or scars can speed healing without needles, but the evidence so far comes only from animal models and lab studies.

By Rx.com Editorial Team · Sources cited · Published Nov 18, 2026 · 12 min read

Topical BPC-157 products promise tendon, joint and skin repair with a simple cream or gel, yet no human clinical trial has ever tested whether the peptide absorbs through intact skin or delivers meaningful healing. Animal studies show faster wound closure when BPC-157 cream is rubbed directly onto burns or ligament injuries, but the peptide’s size and water-solubility make skin penetration uncertain, and the U.S. Food & Drug Administration (FDA) has not approved any BPC-157 cream. If you need systemic effects, prescription compounded BPC-157 injections-available online from Rx.com for $199 month-to-month if prescribed-remain the only regulated option in the United States.

  • Topical BPC-157 accelerated burn wound healing in mice even when corticosteroids slowed recovery, according to a 21-day study (Sikiric et al., 2003).
  • Rat corneal defects closed completely within 40-48 hours when BPC-157 eye drops were applied every 8 hours, versus persistent defects in untreated eyes (Lazić et al., 2005).
  • Creams containing BPC-157 improved ligament strength and histology after surgical injury in rats (Cerovecki et al., 2010).
  • The latest 2026 pharmaceutical review notes zero completed human Phase II trials and no validated topical formulation for BPC-157 (Mateescu et al., 2026).
  • Prescription compounded BPC-157 from Rx.com is offered only as an injectable route: $597 for a six-month plan or $199 month-to-month, billed only if a licensed provider writes a prescription.
Bottom line: Animal data suggest BPC-157 creams can speed wound repair when applied directly to injured tissue, but there is no human evidence, no FDA-approved product and unknown skin absorption-so injections remain the standard clinical route.

Black Friday saleEnds Fri, Nov 27

Buy 3 months, get 3 free

6 months of prescription BPC-157 for $597 ($99.50/mo), or $199 month to month. Prescribed by a U.S.-licensed provider, compounded by a licensed U.S. 503A pharmacy. No code needed, billed only if prescribed. Not FDA approved.

See all Black Friday peptide deals →

Prescription BPC-157 from Rx.com, from $99.50/mo. Online visit with a U.S.-licensed provider, compounded by a licensed U.S. 503A pharmacy. Not FDA approved.

See plans →

What BPC-157 Creams Are-and What They Are Not

BPC-157 cream is a compounded topical preparation that suspends the synthetic peptide in a neutral base intended for skin application. The peptide itself is licensed for research only and is not an FDA-approved drug. Compounding pharmacies sometimes blend BPC-157 powder into creams, gels or ointments on a per-prescription basis, usually at microgram-level concentrations that mirror successful animal experiments. No finished-product manufacturer has submitted a New Drug Application (NDA) for a topical BPC-157 product (fda.gov).

Compounded creams are legal only when a prescriber writes a patient-specific prescription and a 503A pharmacy follows the new Interim Access Policy for compounding certain peptides. Over-the-counter “research use only” BPC-157 lotions sold online are not meant for humans and fall outside this policy.

How Might Topical BPC-157 Work?

Researchers think BPC-157 exerts local growth-factor-like effects that support angiogenesis (new blood vessels) and extracellular matrix remodeling when it contacts injured tissue directly. In rat and mouse models, topical BPC-157 has increased vascular endothelial growth factor (VEGF) expression, accelerated re-epithelialization and improved collagen organization (Huang et al., 2015). The peptide also seems to modulate nitric-oxide signaling, which may explain its ability to counteract local anesthetic-induced corneal numbness when dropped onto the eye (Mirković et al., 2020). However, these mechanistic theories come from animal or cell culture work, not human trials.

What the Animal Studies Show

Every published topical study is preclinical, but together they suggest BPC-157 can speed repair in skin, ligaments, corneas and laser wounds. Key findings are summarized below.

Model (Species) Injury Type & Application Main Outcome With BPC-157 Source
Deep partial-thickness burn (mouse) Cream after 20 % body-surface burn Faster macroscopic and tensile-strength healing despite corticosteroids (Sikiric et al., 2003)
CO2 laser skin wound (mouse) Cream Improved microscopic and macroscopic closure at days 7 & 21 (Bilic et al., 2005)
Medial collateral ligament transection (rat) Cream Higher ligament strength and better histology across 90 days (Cerovecki et al., 2010)
Alkali burn (rat) Topical solution Quicker wound closure and greater collagen deposition by day 18 (Huang et al., 2015)
Corneal debridement (rat) Eye drops Defect resolved by 40-48 h vs ≥48 h in controls (Lazić et al., 2005)

While encouraging, these studies share two major limitations:

  • Direct application to open or surgically exposed tissue. None tested cream on intact human-like skin barriers.
  • No dose-finding or pharmacokinetic data. We do not know what tissue concentrations reached therapeutic thresholds.

Absorption and Stability Challenges

The outer skin layer (stratum corneum) is designed to keep large, water-loving molecules out. Peptides typically require specialized delivery systems-lipid nanoparticles, microneedles, iontophoresis-or an open wound to reach deeper tissue. The 2026 biopharmaceutical review of BPC-157 lists “poor dermal permeability” and “absence of a validated transdermal carrier” among the top development hurdles (Mateescu et al., 2026).

Even if absorption were solved, peptide stability is another obstacle. BPC-157 can hydrolyze in aqueous solutions and may oxidize when repeatedly opened at room temperature (Mateescu et al., 2026). Compounded creams have a short beyond-use date (often 30 days) and must be refrigerated unless the pharmacy proves longer stability.

Current U.S. Access Route Human Evidence of Benefit Regulatory Status Typical Cost
Prescription compounded injection (Rx.com BPC-157) None yet, but systemic delivery confirmed in animals Patient-specific 503A compounding; not FDA-approved $199 month-to-month
$597 six-month plan
Prescription compounded cream/gel No human data Allowed only if prescriber documents a need for topical route under the FDA interim policy Varies; no standardized pricing
“Research use only” cosmetic cream No human data; sourcing unregulated Outside FDA interim policy; not for human use Unlisted

Safety and Regulatory Status

BPC-157-whether injected or smeared on the skin-has never been evaluated in an FDA-reviewed human safety trial. The peptide is not on the FDA’s list of approved bulk drug substances, but it is temporarily allowed for patient-specific compounding under the 2026 Interim Access Policy. That policy can be withdrawn if new safety issues emerge.

Topical use may seem lower risk, but formulations sold as cosmetics can be contaminated or carry inaccurate peptide amounts. Because BPC-157 modulates angiogenesis and nitric-oxide pathways, unknown systemic absorption could theoretically affect blood pressure or interact with anti-platelet medications-another reason to involve a licensed provider.

Why Injections Remain the Standard Route

Clinicians and researchers favor subcutaneous or intramuscular injections because they bypass the skin barrier and achieve measurable systemic exposure in animal models. Injections also allow precise dosing, can be sterile-filtered, and are already used in multiple human Phase I trials overseas. Until a topical carrier proves it can deliver therapeutic levels through intact skin, injections are likely to remain the default for patients who need whole-body or deep-tissue effects.

Should You Try a Topical Product?

The safest path is to treat topical BPC-157 as purely experimental and to discuss it with a qualified health-care provider first. If your goal is localized skin healing-such as a surgical scar-there is at least animal precedent. For joint, tendon or systemic benefits, current science leans toward injections.

Is a topical BPC-157 cream right for your situation?

Check the column that fits your needs:

✅ Consider a cream

  • You have a superficial skin wound or scar under provider supervision
  • You cannot tolerate injections and only want local effect
  • A 503A pharmacy can prepare a fresh, refrigerated batch with documentation

🏥 See a provider about injections instead

  • You need potential systemic benefits (gut, brain, joint)
  • You plan to self-treat with an unregulated research cream
  • Your wound is deep, infected or not healing as expected
  • You take blood-thinners or have cardiovascular disease

🚨 When to Contact Your Healthcare Provider

Seek medical care right away if you notice any of the following while using or considering BPC-157:

  • Rapidly spreading redness, warmth or pus: may indicate infection requiring antibiotics.
  • Severe eye pain or vision changes after using any peptide eye drop.
  • Unexpected bleeding or bruising if you also take anti-platelet or anticoagulant drugs.
  • Chest pain or shortness of breath: could signal a cardiovascular event.
  • Sudden swelling of the face, lips or throat suggesting an allergic reaction.
  • Non-healing wound beyond two weeks despite topical treatment.
  • Systemic symptoms such as dizziness, severe headache or fainting.

Black Friday saleEnds Fri, Nov 27

Buy 3 months, get 3 free

6 months of prescription BPC-157 for $597 ($99.50/mo), or $199 month to month. Prescribed by a U.S.-licensed provider, compounded by a licensed U.S. 503A pharmacy. No code needed, billed only if prescribed. Not FDA approved.

See all Black Friday peptide deals →

Frequently Asked Questions

Can BPC-157 cream penetrate unbroken human skin?

No study has demonstrated meaningful penetration through intact adult skin. All positive experiments applied the peptide directly to an open wound, surgically exposed ligament or debrided cornea.

Is there any human trial of topical BPC-157?

No. The 2026 pharmaceutical review confirms that no Phase II or Phase III human trial has evaluated a BPC-157 cream, gel or ointment (Mateescu et al., 2026).

What concentration do animal studies use?

Effective doses have ranged from about 1 µg of peptide per gram of cream for ligament repair (Cerovecki et al., 2010) to eye-drop concentrations of 2 µg per mL for corneal healing (Lazić et al., 2005). Direct comparisons between studies are difficult because each model, injury and application schedule differs.

Can I buy BPC-157 lotion online without a prescription?

You will find “research use only” creams on the internet, but they are unregulated, may contain little or no active peptide and are not meant for people. They fall outside the FDA’s interim compounding policy and carry quality and contamination risks.

Does Rx.com sell a BPC-157 cream?

Not at this time. Rx.com offers prescription compounded BPC-157 only in an injectable format that a licensed provider may prescribe after an online visit.

Could a cream still help scars even if it does not enter the bloodstream?

Possibly, if the peptide can reach the superficial dermis where collagen remodeling occurs. The animal burn and laser studies suggest local benefit when the barrier is already disrupted, but this has not been proven in humans.

Does BPC-157 cream show up on drug tests?

No standard employment or sports drug screen checks for BPC-157. However, athletes should know that BPC-157 is prohibited by many sports anti-doping agencies.

Where can I read more about peptide absorption issues?

See our in-depth BPC-157 absorption guide for routes, barriers and formulation technologies being explored.

Available now at Rx.com

Prescription BPC-157, from $99.50/mo

An online visit with a U.S.-licensed provider, then BPC-157 compounded for you by a licensed U.S. 503A pharmacy under the FDA's October 2026 interim policy and shipped to your door if it is right for you. Prescription BPC-157 from Rx.com starts at $99.50 a month on the 6-month plan ($597 total). You can also choose 1 month for $199. Each plan is a one-time payment, due only if a provider prescribes it. BPC-157 is not FDA approved.

Compare prices & coupons

Bpc 157

More Peptides guides

Part of our Peptides guide collection.

🧬 See all Peptides guides →

Medical disclaimer: This information is provided for general educational purposes only and is not medical advice. It is not a substitute for professional diagnosis or treatment. Always consult a licensed physician, pharmacist, or other qualified healthcare provider before starting, stopping, or changing any medication or treatment. Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or 911 immediately.

Don't Miss Out On Savings!